A 2006 Phase I trial of CJC-1295 reported no serious adverse events across a small number of subjects, but it was a safety study, not an outcomes trial, and there are no large trials showing it does what enthusiasts hope
Available to buy in the UK from Peptides Lab UK, 5-Amino-1MQ is one of the most extensively characterised selective NNMT inhibitors in current metabolic research, with published pre-clinical evidence spanning adipocyte biology, diet-induced obesity models, NAD+/SAM pathway studies, skeletal muscle function research, and cancer cell biology
Prevention of vitamin B12 deficiency in people who need more vitamin B12 than usual due to certain conditions (such as pregnancy, thyroid problems, liver or kidney problems)
The distinction matters for several reasons: Natural pulsatile release: GH secretagogues maintain normal release patterns rather than creating the sustained elevation from HGH injections